Cardinal Plans Expanded Role In Generic Rx Sector
This article was originally published in The Pink Sheet Daily
Executive Summary
The wholesaler will "participate more in the value chain" for generics via partnerships and use of in-house manufacturing capacity. "Don't interpret that to mean we are going to go buy a generic manufacturer now," CEO Walter says.
You may also be interested in...
Cardinal Steps Up Generics Focus By Establishing “Cross-Segment” Team
Wholesaler downplays effect of Wal-Mart generics program.
Natrecor Use Should Be Limited, Independent Panel Convened By J&J Says
The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.